HuGE Literature Finder
Records
1
-
3
DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia. Clinical and translational science 2020 9 14 (1): 137-142. Buelow Daelynn R, Anderson Jason T, Pounds Stanley B, Shi Lei, Lamba Jatinder K, Hu Shuiying, Gibson Alice A, Goodwin Emily A, Sparreboom Alex, Baker Sharyn |
Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2020 23 (1): 1-9. Wang Qing, Jiang Zhi-Ping, Zeng Jing, Zhu Yan, Cai Hua-Lin, Xiang Da-Xiong, He Qun, Shi Xiao-Liu, Zhong An-Ni, Zhao Xie-Lan, Xu Pi |
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment. Journal of experimental & clinical cancer research : CR 2017 Apr 36 (1): 55. Jaruskova Monika, Curik Nikola, Hercog Rajna, Polivkova Vaclava, Motlova Eliska, Benes Vladimir, Klamova Hana, Pecherkova Pavla, Belohlavkova Petra, Vrbacky Filip, Machova Polakova Kateri |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 16, 2023
- Content source: